Welcome to LookChem.com Sign In|Join Free

CAS

  • or

25245-33-4

Post Buying Request

25245-33-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

25245-33-4 Usage

Uses

1-Iodo-2,3-dimethoxybenzene is used in the preparation of fused heterocyclic amido compounds as a potential anti hepatitis C virus agents.

Check Digit Verification of cas no

The CAS Registry Mumber 25245-33-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,2,4 and 5 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 25245-33:
(7*2)+(6*5)+(5*2)+(4*4)+(3*5)+(2*3)+(1*3)=94
94 % 10 = 4
So 25245-33-4 is a valid CAS Registry Number.

25245-33-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-iodo-2,3-dimethoxybenzene

1.2 Other means of identification

Product number -
Other names 2,3-dimethoxy-1-iodobenzene

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:25245-33-4 SDS

25245-33-4Relevant articles and documents

Aryl iodides from aryllithiums using an iodolactone as an iodine electrophile

Harrowven, David C,Nunn, Michael I.T,Fenwick, David R

, p. 7501 - 7502 (2001)

The paper describes the use of iodolactone 2 as an iodine electrophile for transforming aryllithiums into aryl iodides.

BIARYL DERIVATIVE AS GPR120 AGONIST

-

Paragraph 0112; 0438, (2017/11/17)

The present invention relates to a biaryl derivative expressed by the chemical formula 1, a method for producing the biaryl derivative, a pharmaceutical composition comprising same, and use of same, the biaryl derivative expressed by the chemical formula 1, as a GPR120 agonist, promoting GLP-1 generation in the gastro-intestinal tract, reducing insulin resistance in the liver, muscles and the like from anti-inflammatory activity in the macrophage, pancreatic cells and the like, and allowing effective use in prevention or treatment of inflammation or metabolic diseases such as diabetes, complications from diabetes, obesity, non-alcoholic fatty liver disease, fatty liver disease, and osteoporosis.

THERAPEUTIC AGENT FOR HEPATITIS C

-

Page/Page column 24, (2013/02/27)

This invention provides a therapeutic agent for hepatitis C comprising, as an active ingredient, a compound having anti-HCV activity useful in treatment of hepatitis C. The therapeutic agent for hepatitis C comprises, as an active ingredient, a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 25245-33-4